Blood Thinner Pradaxa Cases Consolidated in MDL

Pradaxa is a prescription blood thinner used to prevent strokes and blood clots in people with atrial fibrillation not caused by a heart valve problem.  Unlike a similar drug on the market, Coumadin, there are serious bleeding and cardiac risks with Pradaxa because there is no reversal agent to counteract Pradaxa’s anticoagulation effects.
The United States Judicial Panel on Multidistrict Litigation (JPML) recently consolidated  all federal court Pradaxa drug injury lawsuits into the following case: IN RE: PRADAXA (DABIGATRAN ETEXILATE) PRODUCTS LIABILITY LITIGATION, MDL No. 2385.